Screener
NeoGenomics NEO Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| NET REVENUE | $201,656 | $181,330 | $388,328 | $349,365 |
| COST OF REVENUE | 109,778 | 104,072 | 215,586 | 198,861 |
| GROSS PROFIT | 91,878 | 77,258 | 172,742 | 150,504 |
| Operating expenses: | ||||
| General and administrative | 63,613 | 71,747 | 129,354 | 139,954 |
| Research and development | 10,761 | 9,023 | 20,295 | 19,204 |
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's total cost of revenue?
- NeoGenomics (NEO) reported total cost of revenue of $109.78M in Q2 2026.
- How has NeoGenomics's total cost of revenue changed year-over-year?
- NeoGenomics's total cost of revenue increased by 5.5% year-over-year, from $104.07M to $109.78M.
- What is the long-term trend for NeoGenomics's total cost of revenue?
- Over 4 years (2021 to 2025), NeoGenomics's total cost of revenue has grown at a 8.6% compound annual growth rate (CAGR), from $297.27M to $413.04M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about NeoGenomics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude